Cordyceps Sunshine Biotech Holdings Co., Ltd.
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF): ~25 mo cash runway. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
25.2 months
D/E -9.71 · 0% dilution
N/A
N/A
N/A
N/A
A transparent, data-derived signal for Cordyceps Sunshine Biotech Holdings Co., Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.0B
Cash
$3K
Quarterly Burn
$36K
Runway
25.2 mo
Revenue
$1.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Frequently asked questions
What is Cordyceps Sunshine Biotech Holdings Co., Ltd.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Cordyceps Sunshine Biotech Holdings Co., Ltd. has approximately 25.2 months of cash runway.
What is Cordyceps Sunshine Biotech Holdings Co., Ltd.'s market capitalization?
Cordyceps Sunshine Biotech Holdings Co., Ltd.'s market capitalization is approximately $1.0B.
Who is the CEO of Cordyceps Sunshine Biotech Holdings Co., Ltd.?
Mr. Szu Hao Huang is the chief executive officer of Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF).
Get the full picture on Cordyceps Sunshine Biotech Holdings Co., Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.